Daskal Ilan's most recent trade in Viavi Solutions Inc was a trade of 30,257 Common Stock done at an average price of $36.3 . Disclosure was reported to the exchange on Aug. 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 36.29 per share. | 31 Aug 2026 | 30,257 | 36,165 (0%) | 0% | 36.3 | 1,098,027 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 36.29 per share. | 31 Aug 2026 | 26,033 | 10,132 (0%) | 0% | 36.3 | 944,738 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2026 | 55,114 | 55,114 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2026 | 55,114 | 65,246 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2026 | 47,420 | 94,838 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2026 | 47,420 | 87,809 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2026 | 34,861 | 34,861 | - | - | Restricted Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2026 | 34,861 | 34,861 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.54 per share. | 28 Aug 2026 | 24,857 | 40,389 (0%) | 0% | 36.5 | 908,275 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.54 per share. | 28 Aug 2026 | 21,387 | 66,422 (0%) | 0% | 36.5 | 781,481 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 17.43 per share. | 02 Dec 2025 | 105,191 | 10,132 (0%) | 0% | 17.4 | 1,833,479 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 17.42 per share. | 02 Dec 2025 | 39,709 | 115,323 (0%) | 0% | 17.4 | 691,731 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 17.84 per share. | 02 Dec 2025 | 25,100 | 155,032 (0%) | 0% | 17.8 | 447,784 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 65,944 | 131,886 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 65,944 | 189,078 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 62,645 | 131,888 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 62,645 | 131,632 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 37,879 | 197,216 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 37,879 | 37,878 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 35,984 | 37,880 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 35,984 | 139,363 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.94 per share. | 28 Nov 2025 | 29,741 | 159,337 (0%) | 0% | 17.9 | 533,554 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.94 per share. | 28 Nov 2025 | 28,253 | 103,379 (0%) | 0% | 17.9 | 506,859 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.94 per share. | 28 Nov 2025 | 17,084 | 180,132 (0%) | 0% | 17.9 | 306,487 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.94 per share. | 28 Nov 2025 | 16,229 | 123,134 (0%) | 0% | 17.9 | 291,148 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2025 | 70,545 | 110,229 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2025 | 70,545 | 100,803 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2025 | 62,645 | 131,888 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2025 | 35,984 | 37,880 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.41 per share. | 23 Sep 2025 | 31,816 | 68,987 (0%) | 0% | 12.4 | 394,837 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2025 | 142,258 | 142,258 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2025 | 142,258 | 142,258 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2025 | 55,115 | 110,228 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2025 | 55,115 | 55,115 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.27 per share. | 28 Aug 2025 | 24,857 | 30,258 (0%) | 0% | 11.3 | 280,138 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Sale of securities on an exchange or to another person at price $ 9.28 per share. | 04 Jun 2025 | 82,095 | 0 (0%) | 0% | 9.3 | 761,842 | Common Stock |
| Viavi Soln Inc | Daskal Ilan | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 65,944 | 197,830 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Daskal Ilan | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 65,944 | 96,835 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 39,783 | 39,783 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Daskal Ilan | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 39,783 | 197,831 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 37,879 | 75,757 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 37,879 | 101,293 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 28 Nov 2024 | 33,421 | 63,414 (0%) | 0% | 9.9 | 330,199 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 22,851 | 42,472 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2024 | 22,851 | 75,758 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 28 Nov 2024 | 20,162 | 19,621 (0%) | 0% | 9.9 | 199,201 | Common Stock |
| Viavi Soln Inc | Daskal Ilan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 28 Nov 2024 | 19,198 | 82,095 (0%) | 0% | 9.9 | 189,676 | Common Stock |
| Viavi Soln Inc | Daskal Ilan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 28 Nov 2024 | 11,581 | 30,891 (0%) | 0% | 9.9 | 114,420 | Common Stock |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 39,783 | 39,783 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 22,851 | 22,851 | - | - | Market Stock Units | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 165,343 | 165,343 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Ilan Daskal | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 165,343 | 165,343 | - | - | Market Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 4,007 | 4,007 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 694 | 2,082 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 694 | 2,206 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 542 | 542 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 542 | 2,755 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 456 | 912 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 456 | 2,422 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 269 | 2,486 (0%) | 0% | 394.6 | 106,147 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 240 | 1,966 (0%) | 0% | 394.6 | 94,704 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 209 | 2,213 (0%) | 0% | 394.6 | 82,471 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2023 | 700 | 700 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2023 | 700 | 1,736 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.24 per share. | 08 Apr 2023 | 243 | 1,493 (0%) | 0% | 466.2 | 113,296 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 541 | 1,084 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 541 | 1,222 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 269 | 953 (0%) | 0% | 478.3 | 128,668 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,776 | 2,776 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 455 | 1,368 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 455 | 907 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 226 | 681 (0%) | 0% | 486.3 | 109,893 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 700 | 709 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 700 | 1,400 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 597.16 per share. | 08 Apr 2022 | 257 | 452 (0%) | 0% | 597.2 | 153,470 | Bio-Rad A Common Stock |